Dow Up 0.36% Nasdaq Up 0.12%

Geron Corporation (GERN)

-NasdaqGS
2.32 0.04(1.69%) Aug 21, 4:00PM EDT
|After Hours : 2.32 Down 0.00 (0.02%) Aug 21, 4:56PM EDT
Prev Close:2.36
Open:2.35
Bid:2.30 x 15000
Ask:2.36 x 7000
1y Target Est:4.13
Beta:2.49
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:2.31 - 2.37
52wk Range:1.31 - 7.36
Volume:1,564,088
Avg Vol (3m):4,281,060
Market Cap:363.97M
P/E (ttm):N/A
EPS (ttm):-0.26
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNDown 1.69%363.97M
BMY82.88B
GSK114.58B
NVS215.81B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):303.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.23
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-2.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback